| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ALX1 | IGFBP5 | ENSAMEP00000009512 | ENSAMEP00000003543 | ALX homeobox 1. | Insulin like growth factor binding protein 5. | 0.455 |
| FAM20C | IGFBP5 | ENSAMEP00000003110 | ENSAMEP00000003543 | FAM20C golgi associated secretory pathway kinase. | Insulin like growth factor binding protein 5. | 0.545 |
| G1LIG6_AILME | IGF2 | ENSAMEP00000006719 | ENSAMEP00000002277 | IlGF domain-containing protein. | Insulin like growth factor 2. | 0.532 |
| G1LIG6_AILME | IGFBP5 | ENSAMEP00000006719 | ENSAMEP00000003543 | IlGF domain-containing protein. | Insulin like growth factor binding protein 5. | 0.918 |
| G1LIG6_AILME | IGFBP7 | ENSAMEP00000006719 | ENSAMEP00000009052 | IlGF domain-containing protein. | Insulin like growth factor binding protein 7. | 0.673 |
| G1LIG6_AILME | INS-IGF2 | ENSAMEP00000006719 | ENSAMEP00000002279 | IlGF domain-containing protein. | INS-IGF2 readthrough; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.638 |
| G1LIG6_AILME | PAPPA | ENSAMEP00000006719 | ENSAMEP00000013048 | IlGF domain-containing protein. | Pappalysin 1. | 0.502 |
| IGF1 | IGF2 | ENSAMEP00000006724 | ENSAMEP00000002277 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | Insulin like growth factor 2. | 0.951 |
| IGF1 | IGFBP5 | ENSAMEP00000006724 | ENSAMEP00000003543 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | Insulin like growth factor binding protein 5. | 0.918 |
| IGF1 | IGFBP7 | ENSAMEP00000006724 | ENSAMEP00000009052 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | Insulin like growth factor binding protein 7. | 0.673 |
| IGF1 | INS-IGF2 | ENSAMEP00000006724 | ENSAMEP00000002279 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | INS-IGF2 readthrough; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.962 |
| IGF1 | PAPPA | ENSAMEP00000006724 | ENSAMEP00000013048 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | Pappalysin 1. | 0.502 |
| IGF2 | G1LIG6_AILME | ENSAMEP00000002277 | ENSAMEP00000006719 | Insulin like growth factor 2. | IlGF domain-containing protein. | 0.532 |
| IGF2 | IGF1 | ENSAMEP00000002277 | ENSAMEP00000006724 | Insulin like growth factor 2. | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | 0.951 |
| IGF2 | IGFBP5 | ENSAMEP00000002277 | ENSAMEP00000003543 | Insulin like growth factor 2. | Insulin like growth factor binding protein 5. | 0.880 |
| IGF2 | IGFBP7 | ENSAMEP00000002277 | ENSAMEP00000009052 | Insulin like growth factor 2. | Insulin like growth factor binding protein 7. | 0.472 |
| IGF2 | INS-IGF2 | ENSAMEP00000002277 | ENSAMEP00000002279 | Insulin like growth factor 2. | INS-IGF2 readthrough; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.706 |
| IGF2 | PAPPA | ENSAMEP00000002277 | ENSAMEP00000013048 | Insulin like growth factor 2. | Pappalysin 1. | 0.585 |
| IGF2 | PAPPA2 | ENSAMEP00000002277 | ENSAMEP00000018096 | Insulin like growth factor 2. | Pappalysin 2. | 0.462 |
| IGFBP5 | ALX1 | ENSAMEP00000003543 | ENSAMEP00000009512 | Insulin like growth factor binding protein 5. | ALX homeobox 1. | 0.455 |